You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
領航醫藥生物科技(00399.HK)擬折讓約17.84%配售最多2.06億股 淨籌3552萬港元

格隆匯5月29日丨領航醫藥生物科技(00399.HK)公吿,於2025年5月29日,公司與配售代理訂立配售協議,據此,配售代理已有條件同意擔任公司代理,以竭誠促使目前預期不少於六名承配人(彼等及其最終實益擁有人應為獨立第三方)按每股配售股份0.175港元的配售價認購最多206,400,000股配售股份。

假設公司已發行股本於本公吿日期至完成配售事項日期期間不會有變,最多206,400,000股配售股份佔於本公吿日期公司現有已發行股本約11.32%;每股配售股份0.175港元的配售價較股份於2025年5月29日(即配售協議日期)在聯交所所報收市價每股0.213港元折讓約17.84%;所得款項淨額估計約為3552萬港元。公司擬將配售事項所得款項淨額全數用作集團的一般營運資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account